CD4 and neoplasm: Treatment with STYMIE #22 and #30 resulted in the highest increase in tumor‐infiltrating CD4+ T cells, CD8+ T cells, and NK cells (Figure 6e), whereas neutrophils, macrophages, and B cells remained largely unaffected across all treatment and control groups (Figure S13, Supporting Information).